Active

Apogem Capital

Investor type

PE / VC

Founded

2022

AUM

$44 000 M

Location

Chicago, Illinois, United States

Investment Ticket

$10-50 m

Investment Stage

Pre-seed Seed Series A Series B Late Stage (Series C+)

Region of investment

North America
Investor profile last updated: 23 May, 2026

Profile

Apogem Capital is a leading alternatives investment manager with decades of experience investing in the middle market.

Apogem Capital was created by combining three leading middle market investment firms—GoldPoint Partners, Madison Capital Funding, and PA Capital—into a single unified investment firm. Together, we offer comprehensive investment capabilities in private equity, private credit, and real assets.

Apogem Capital manages $42 billion in AUM* and is a wholly owned subsidiary of New York Life Insurance Company, one of the world’s largest life insurers.

Industry

Financial Services Fintech Healthcare Services Energy CleanTech HealthTech Business Services (B2B) Consumer Products Consumer Services (B2C) SaaS Software Technology Industrial Security

Apogem Capital Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Apogem Secondary Fund VII
Private Equity (PE)
Financial Services
Fintech
Healthcare Services
Energy
CleanTech
HealthTech
Pre-seed
Seed
North America
$5-10 m
$776 M
February 2025
PA Secondary Fund VI
Private Equity (PE)
Healthcare Services
Energy
HealthTech
Series B
Late Stage (Series C+)
North America
$5-10 m
$614 M
June 2022
PA Small Company Private Equity Fund IX
Private Equity (PE)
Business Services (B2B)
Consumer Products
Consumer Services (B2C)
Healthcare Services
SaaS
Software
Technology
Series B
Late Stage (Series C+)
North America
$5-10 m
$673 M
March 2015
PA Secondary Fund V
Private Equity (PE)
Healthcare Services
Industrial
SaaS
Security
Software
Technology
Series B
Late Stage (Series C+)
North America
$5-10 m
$14 M
March 2016
Apogem Private Equity Fund XI Cayman
Private Equity (PE)
Financial Services
Fintech
Healthcare Services
Energy
HealthTech
Series B
Late Stage (Series C+)
North America
$5-10 m
$75 M
May 2026

Contacts

Name
Title
Email
avatar
Frantz Paulus Managing Director, Head of Private Credit Business Development
Managing Director, Head of Private Credit Business Development
f•••@•••
avatar
Louise Woltz Smith Managing Director
Managing Director
l•••@•••
Upgrade to see contacts
avatar
CvXkDLEJtheQc6Up CvXkDLEJtheQc6Up
CvXkDLEJtheQc6Up
avatar
CvXkDLEJtheQc6Up CvXkDLEJtheQc6Up
CvXkDLEJtheQc6Up
avatar
CvXkDLEJtheQc6Up CvXkDLEJtheQc6Up
CvXkDLEJtheQc6Up
Investment-team contacts for Apogem Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Apogem Capital

Apogem Capital is a venture capital and private equity firm. It backs companies at Pre-seed, Seed, Series A, Series B and Late Stage (Series C+), writing tickets of $10-50 m.
Apogem Capital is located in Chicago, Illinois, United States.
Apogem Capital was founded in 2022.
Apogem Capital invests in companies and startups in Financial Services, Fintech, Healthcare Services, Energy, CleanTech, HealthTech, Business Services (B2B), Consumer Products, Consumer Services (B2C), SaaS, Software, Technology, Industrial, Security.
Apogem Capital invests in companies and startups in North America.
Apogem Capital invests in companies and startups at Pre-seed, Seed, Series A, Series B, Late Stage (Series C+).
Apogem Capital usually invests $10-50 m on average.
Apogem Capital has around $44 000m assets under management.
Apogem Capital last fund was created/launched in 2026-05-21
Apogem Capital can be reached through its website apogemcapital.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Apogem Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Apogem Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 23 May, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.